Table 2.
Independent variables after survival analysis (Cox regression).
Diffuse type gastric cancer | Intestinal type gastric cancer | ||||||||
---|---|---|---|---|---|---|---|---|---|
Overall survival | Tumor specific survival | Overall survival | |||||||
HR | 95% CI | p Value | HR | 95% CI | p Value | HR | 95% CI | p Value | |
Stage | < 0.001 | < 0.001 | 0.002 | ||||||
II versus I | 3.290 | 0.761–14.218 | 0.111 | 5.877 | 0.775–44.590 | 0.087 | 2.511 | 1.411–4.470 | 0.002 |
III versus I | 7.240 | 1.745–30.036 | 0.006 | 15.231 | 2.072–112.0 | 0.007 | 2.679 | 1.427–5.030 | 0.002 |
IV versus I | 9.557 | 2.225–41.056 | 0.002 | 19.337 | 2.581–144.9 | 0.004 | 3.828 | 1.855–7.900 | < 0.001 |
LNR (high vs. low) | 2.149 | 1.351–3.420 | 0.001 | ||||||
pV (V1 vs. V0) | 2.268 | 1.014–5.071 | 0.046 | ||||||
pR (R1/R2 vs. R0) | 3.030 | 1.731–5.302 | < 0.001 | 3.160 | 1.811–5.512 | < 0.001 | 2.558 | 1.406–4.655 | 0.002 |
HER2 status (positive vs. negative) | 4.238 | 1.493–12.032 | 0.007 | 3.767 | 1.330–10.670 | 0.013 | |||
FZD7 status | 1.567 | 1.126–2.180 | 0.008 | ||||||
RNF43 (low vs. high) | 2.393 | 1.333–3.226 | 0.001 | 2.398 | 1.488–3.861 | < 0.001 |
Included were all variables having p < 0.100 in univariate survival analysis (log-rank test), i.e., UICC stage, lymph node ratio, L category, V category, R status, HER2-status, and RNF43 for diffuse subgroup, and UICC stage, lymph node ratio (LNR), L category, R status, FZD7 status, and RNF43 for intestinal subgroup.